PROM1 and neoplasm: It is therefore not surprising that once re-established in NOD/SCID mice, tumors derived from treated patients did not demonstrate any sustained enrichment in ALDHhigh or CD133+ cell populations compared to tumors derived from untreated patient tumor specimens.